Anil Parsram Bidkar, PhD

Title(s)Postdoctoral Scholar, Radiology
SchoolSchool of Medicine
Address185 Berry Street Bldg B, #340-2
San Francisco CA 94107
Phone415-646-6455
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. PET Imaging Using 89Zr Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention (EPR) in Prostate Cancer. Mol Cancer Ther. 2024 Sep 27. Meher N, Bidkar AP, Wadhwa A, Bobba KN, Dhrona S, Dasari C, Mu C, Fong COY, Cámara JA, Ali U, Basak M, Bulkley D, Steri V, Fontaine SD, Zhu J, Oskowitz A, Aggarwal RR, Sriram R, Chou J, Wilson DM, Seo Y, Santi DV, Ashley GW, VanBrocklin HF, Flavell RR. PMID: 39331510.
      View in: PubMed   Mentions:    Fields:    
    2. 3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer. Sci Rep. 2024 08 27; 14(1):19938. Peter R, Bidkar AP, Bobba KN, Zerefa L, Dasari C, Meher N, Wadhwa A, Oskowitz A, Liu B, Miller BW, Vetter K, Flavell RR, Seo Y. PMID: 39198676; PMCID: PMC11358493.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    3. A Technique to Quantify Very Low Activities in Regions of Interest With a Collimatorless Detector. IEEE Trans Med Imaging. 2024 Aug; 43(8):2745-2757. Caravaca J, Bobba KN, Du S, Peter R, Gullberg GT, Bidkar AP, Flavell RR, Seo Y. PMID: 38478457; PMCID: PMC11293990.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    4. Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer. Adv Healthc Mater. 2024 Jul; 13(19):e2304618. Meher N, Ashley GW, Bobba KN, Wadhwa A, Bidkar AP, Dasari C, Mu C, Sankaranarayanan RA, Serrano JAC, Raveendran A, Bulkley DP, Aggarwal R, Greenland NY, Oskowitz A, Wilson DM, Seo Y, Santi DV, VanBrocklin HF, Flavell RR. PMID: 38700450; PMCID: PMC11281871.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    5. Actinium-225 targeted alpha particle therapy for prostate cancer. Theranostics. 2024; 14(7):2969-2992. Bidkar AP, Zerefa L, Yadav S, VanBrocklin HF, Flavell RR. PMID: 38773983; PMCID: PMC11103494.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    6. CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma. Clin Cancer Res. 2024 03 01; 30(5):1009-1021. Wadhwa A, Wang S, Patiño-Escobar B, Bidkar AP, Bobba KN, Chan E, Meher N, Bidlingmaier S, Su Y, Dhrona S, Geng H, Sarin V, VanBrocklin HF, Wilson DM, He J, Zhang L, Steri V, Wong SW, Martin TG, Seo Y, Liu B, Wiita AP, Flavell RR. PMID: 38109209; PMCID: PMC10905524.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    7. Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5. Theranostics. 2024; 14(4):1344-1360. Bobba KN, Bidkar AP, Wadhwa A, Meher N, Drona S, Sorlin AM, Bidlingmaier S, Zhang L, Wilson DM, Chan E, Greenland NY, Aggarwal R, VanBrocklin HF, He J, Chou J, Seo Y, Liu B, Flavell RR. PMID: 38389832; PMCID: PMC10879874.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    8. Highly efficient color-tunable organic co-crystals unveiling polymorphism, isomerism, delayed fluorescence for optical waveguides and cell-imaging. Nat Commun. 2023 Oct 20; 14(1):6648. Barman D, Annadhasan M, Bidkar AP, Rajamalli P, Barman D, Ghosh SS, Chandrasekar R, Iyer PK. PMID: 37863932; PMCID: PMC10589249.
      View in: PubMed   Mentions: 2     Fields:    
    9. Coded aperture and Compton imaging for the development of 225 Ac-based radiopharmaceuticals. Med Phys. 2023 Oct; 50(10):6454-6468. Frame E, Bobba K, Gunter D, Mihailescu L, Bidkar A, Flavell R, Vetter K. PMID: 37672346.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    10. Evaluation of 134Ce/134La as a PET Imaging Theranostic Pair for 225Ac α-Radiotherapeutics. J Nucl Med. 2023 07; 64(7):1076-1082. Bobba KN, Bidkar AP, Meher N, Fong C, Wadhwa A, Dhrona S, Sorlin A, Bidlingmaier S, Shuere B, He J, Wilson DM, Liu B, Seo Y, VanBrocklin HF, Flavell RR. PMID: 37201957; PMCID: PMC10315697.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    11. Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy. Clin Cancer Res. 2023 05 15; 29(10):1916-1928. Bidkar AP, Wang S, Bobba KN, Chan E, Bidlingmaier S, Egusa EA, Peter R, Ali U, Meher N, Wadhwa A, Dhrona S, Dasari C, Beckford-Vera D, Su Y, Tang R, Zhang L, He J, Wilson DM, Aggarwal R, VanBrocklin HF, Seo Y, Chou J, Liu B, Flavell RR. PMID: 36917693; PMCID: PMC10183825.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    12. CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment. J Exp Clin Cancer Res. 2023 Mar 11; 42(1):61. Li J, Huang T, Hua J, Wang Q, Su Y, Chen P, Bidlingmaier S, Li A, Xie Z, Bidkar AP, Shen S, Shi W, Seo Y, Flavell RR, Gioeli D, Dreicer R, Li H, Liu B, He J. PMID: 36906664; PMCID: PMC10007843.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    13. Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer. Cancer Res. 2023 01 18; 83(2):301-315. Chou J, Egusa EA, Wang S, Badura ML, Lee F, Bidkar AP, Zhu J, Shenoy T, Trepka K, Robinson TM, Steri V, Huang J, Wang Y, Small EJ, Chan E, Stohr BA, Ashworth A, Delafontaine B, Rottey S, Cooke KS, Hashemi Sadraei N, Yu B, Salvati M, Bailis JM, Feng FY, Flavell RR, Aggarwal R. PMID: 36351060; PMCID: PMC10263373.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    14. Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers. ACS Appl Mater Interfaces. 2022 Nov 16; 14(45):50569-50582. Meher N, Ashley GW, Bidkar AP, Dhrona S, Fong C, Fontaine SD, Beckford Vera DR, Wilson DM, Seo Y, Santi DV, VanBrocklin HF, Flavell RR. PMID: 36318757; PMCID: PMC9673064.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    15. Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen. ACS Appl Mater Interfaces. 2021 Nov 24; 13(46):54739-54752. Meher N, Seo K, Wang S, Bidkar AP, Fogarty M, Dhrona S, Huang X, Tang R, Blaha C, Evans MJ, Raleigh DR, Jun YW, VanBrocklin HF, Desai TA, Wilson DM, Ozawa T, Flavell RR. PMID: 34752058.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    16. Developing membrane-derived nanocarriers for ex vivo therapy of homologous breast cancer cells. Nanomedicine (Lond). 2021 09; 16(21):1843-1856. Saha M, Bidkar AP, Ghosh SS. PMID: 34369819.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    17. A conformational tweak for enhanced cellular internalization, photobleaching resistance and prolonged imaging efficacy. Chem Commun (Camb). 2020 Nov 26; 56(94):14861-14864. Meher N, Bidkar AP, Barman D, Ghosh SS, Iyer PK. PMID: 33174881.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    18. Effect of Secondary Structure and Side Chain Length of Hydrophobic Amino Acid Residues on the Antimicrobial Activity and Toxicity of 14-Residue-Long de novo AMPs. ChemMedChem. 2021 01 19; 16(2):355-367. Pandit G, Chowdhury N, Abdul Mohid S, Bidkar AP, Bhunia A, Chatterjee S. PMID: 33026188.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    19. Peptide Hydrogels as Platforms for Sustained Release of Antimicrobial and Antitumor Drugs and Proteins. ACS Appl Bio Mater. 2020 Sep 21; 3(9):6251-6262. Roy K, Pandit G, Chetia M, Sarkar AK, Chowdhuri S, Bidkar AP, Chatterjee S. PMID: 35021757.
      View in: PubMed   Mentions: 5     Fields:    
    20. Nerve growth factor from Indian Russell's viper venom (RVV-NGFa) shows high affinity binding to TrkA receptor expressed in breast cancer cells: Application of fluorescence labeled RVV-NGFa in the clinical diagnosis of breast cancer. Biochimie. 2020 Sep; 176:31-44. Islam T, Majumder M, Bidkar A, Ghosh SS, Mukhopadhyay R, Utkin Y, Mukherjee AK. PMID: 32585227.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    21. Rationally designed antimicrobial peptides: Insight into the mechanism of eleven residue peptides against microbial infections. Biochim Biophys Acta Biomembr. 2020 04 01; 1862(4):183177. Pandit G, Biswas K, Ghosh S, Debnath S, Bidkar AP, Satpati P, Bhunia A, Chatterjee S. PMID: 31954105.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    22. Red Blood Cell-Membrane-Coated Poly(Lactic-co-glycolic Acid) Nanoparticles for Enhanced Chemo- and Hypoxia-Activated Therapy. ACS Appl Bio Mater. 2019 Sep 16; 2(9):4077-4086. Bidkar AP, Sanpui P, Ghosh SS. PMID: 35021341.
      View in: PubMed   Mentions: 12     Fields:    
    23. Deciphering Hydrodynamic and Drug-Resistant Behaviors of Metastatic EMT Breast Cancer Cells Moving in a Constricted Microcapillary. J Clin Med. 2019 Aug 09; 8(8). Nath B, Bidkar AP, Kumar V, Dalal A, Jolly MK, Ghosh SS, Biswas G. PMID: 31404980; PMCID: PMC6722803.
      View in: PubMed   Mentions: 6  
    24. Combination Therapy with MAPK-Pathway-Specific Inhibitor and Folic-Acid-Receptor-Targeted Selenium Nanoparticles Induces Synergistic Antiproliferative Response in BRAF Mutant Cancer Cells. ACS Biomater Sci Eng. 2019 May 13; 5(5):2222-2234. Bidkar AP, Sanpui P, Ghosh SS. PMID: 33405774.
      View in: PubMed   Mentions: 3     Fields:    
    25. Insights into the Mechanism of Antimicrobial Activity of Seven-Residue Peptides. J Med Chem. 2018 09 13; 61(17):7614-7629. Pandit G, Ilyas H, Ghosh S, Bidkar AP, Mohid SA, Bhunia A, Satpati P, Chatterjee S. PMID: 30070835.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    26. Efficient induction of apoptosis in cancer cells by paclitaxel-loaded selenium nanoparticles. Nanomedicine (Lond). 2017 Nov; 12(21):2641-2651. Bidkar AP, Sanpui P, Ghosh SS. PMID: 29043926.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    27. Studying in vitro phagocytosis of apoptotic cancer cells by recombinant GMCSF-treated RAW 264.7 macrophages. Int J Biol Macromol. 2017 Sep; 102:1138-1145. Selvarajan V, Bidkar AP, Shome R, Banerjee A, Chaubey N, Ghosh SS, Sanpui P. PMID: 28476594.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    28. Protein folding and misfolding in the neurodegenerative disorders: a review. Rev Neurol (Paris). 2014 Mar; 170(3):151-61. Bolshette NB, Thakur KK, Bidkar AP, Trandafir C, Kumar P, Gogoi R. PMID: 24613386.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    Anil Parsram's Networks
    Concepts (148)
    Derived automatically from this person's publications.
    _
    Co-Authors (32)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _